There hasn’t been an industry till date that has not witnessed the dynamic innovation powered by Nanotechnology- and thankfully, Pharma is no different! The influence of the applications of nanotechnology in the healthcare sector has been considerate. So how is nanotechnology influencing the dynamic Pharma industry?
The Ground Reality!
From accessing medicines to defining product quality, assisting supply chain, and manning ethics in sales and marketing, there are quite a lot nanotechnology-enabled factors that have been influencing the tremendous scopes of Pharma industry. It wouldn’t be wrong to say that this form of science has been creating new horizons for the Pharma sector. As far as the approach is concerned, the practices powered by nanotechnology all together are more opportunity enabled than anything risky.
Nanotechnology and Pharma- The Beginning of the Process!
In simple words, Nano resembles a ‘small’ particle. It is rather a particle that is small yet has larger surface area to quickly absorb in the blood stream. According to Dr. David Hollinshead, “Nanomedicines are a better form of medicines as already many pharmaceutical companies have started using this form of technology to assist the purpose of drug delivery and targeting. For instance, if we take the example of oncology, we will find that the science is already using Nanomedicines to test their respective ability of reaching cell targets. The same process, when used with some conventional medicines, was tiresome and less accurate.
Medicine is indeed a big business and some of the renounced Pharma companies have time-to-time selected innovation to redefine the industry in the finest way. In the year 2007, the combined worth of top ten Pharma companies was about $73 billion and more. Approximately ten years later i.e. today, can you estimate the actual worth of this industry? Yes- it is ever-rising and phenomenally sky high. It is absolutely needless to say that Nanotechnology today has the ultimate potential of transforming the digital health industry. The spread of nanoparticles that will freely flow in human body to detect early signs of diseases (be it cancer, heart attack or brain related problems) is an absolute innovation powered by nanotechnology.
Nanotechnology has been assisting the fundamental shift in medicine, making diagnostics more profound and easy to navigate. The future scope of ‘stage zero disease’ is nothing but an ideal state of healthy world. By determining the cell (and not waiting for the formulation of tumor), the medical world will be able to diagnose the potential attack for superior clinical interventions.
A few years back, the discovery of producing graphene in the easiest manner brought changes in the dynamics of the electronic industry. Needless to say, nothing remained same after the unearthing of this incredible material that was both phenomenal in its strength and ability to conduct heat and electricity. What would have been better than having a transparent material for the advanced level of touchscreen interface? Similarly, in the world enabled with 3D printing, the onset of graphene-based filaments and quality printing material is nothing less than absolute innovation.
The vision of 3D printing was so acute and powerpacked that Graphene 3D Labs, one of the prime reseller and researchers of the material, has eventually bought its parent organization Graphene Laboratories according to a recent press release shared by the company. The recent shareholder update has shared the much speculated news where Co-CEO Elena Polyakova discussed the potential future of the company. The news that has created buzz has also declared the onset of new ‘Industrial Materials Division’.
All that You Need to Know about Graphene 3D Labs new Industrial Materials Division:
With the purchase of Graphene Laboratories, the company will continue to produce and sell graphene through the popular Graphene Supermarket. The development of advanced level of graphene 3D printing materials between both the companies will go exactly the way it was in the past. The third line of business i.e. the Industrial Materials Division is all set to develop some high volume graphene-infused polymers. The material will be thoroughly used in different industries like automotive, robotics, drone, aerospace, military, and so on.
Graphene 3D Labs initiated the new Industrial Material Division with the onset of State-of-the-Art twin-screw extruder that was first manufactured and developed by Thermo Fisher, a science research tech developer. Reportedly, the company has completed the installation and testing process to implement the working stage of this extruder. As suggested, the extruder marks an important step in the manufacturing and production of industrial -grade materials. If rumors are to believe then these new materials have been deemed as lighter, stronger and a more flexible option that anything currently used by the industries.
It is notable that the company was planning to launch the Industrial Material Division for past one year now. With the onset of extruder technology, the company is now able to quickly produce the fine polymer composites, which will eventually allow them to grow by leaps and bounds in the graphene-enabled industry. Ideally, the company is in the winning spot to secure graphene-related knowledge, innovation and commercialized innovation.